News

GLP-1 (glucagon-like peptide-1) therapies can be powerful tools in managing obesity, with patients taking these medications ...
It is important to note that Ozempic and blindness are not usually connected, and vision loss is not a commonly reported or an expected side effect of this weight loss drug. However, if you are on ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
‘Ozempic teeth’ is the unofficial term for a number of dental issues that people who use Ozempic begin to experience, which ...
Diabetic shock is mostly caused by very high or low blood sugar and is a medical emergency that can be fatal if untreated. According to doctors, it is important to recognize symptoms early to ensure ...
Diabetes is characterized by the pancreas producing too little insulin, but there is a rarer condition in which it produces too much ...
Pheochromocytoma because of the risk of substantial increase in blood pressure Insulinoma because of the risk of hypoglycemia Prior hypersensitivity reaction to glucagon or to any of the excipients.
The FDA approved Gvoke, a ready-to-use glucagon product, for the treatment of severe hypoglycemia in 2019. The format is potentially more convenient than traditional glucagon kits from the likes ...
The two organizations will work together on a campaign to raise awareness about the importance of glucagon. According to the ADA, nearly half of all people with type 1 diabetes suffer from at least ...
Glucagon levels in the blood may rise 3-4-fold with hypoglycemia or during exercise, and it is a lifesaving homeostatic hormone in severe hypoglycemia. In prolonged fasting, glucagon primarily ...
Additionally, they observed that if the micelles containing glucagon were injected into mice not in response to a hypoglycemic event, they remained intact and didn’t release the hormone unless ...
The team also determined that glucagon-packed micelles stayed intact in mice and didn’t release the hormone unless blood glucose levels fell below the clinical threshold for severe hypoglycemia.